One Night of Poor Sleep Could Equal Six Months on a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
One Night of Poor Sleep Could Equal Six Months on a High-Fat Diet, Study Shows

LOS ANGELES, Nov. 5, 2015 (GLOBE NEWSWIRE) -- New research finds that one night of sleep deprivation and six months on a high-fat diet could both impair insulin sensitivity to a similar degree, demonstrating the importance of a good night's sleep on health. This study, conducted by Josiane Broussard, PhD, and colleagues from Cedars-Sinai Medical Center in Los Angeles, CA, used a canine model to examine whether sleep deprivation and a high-fat diet affect insulin sensitivity in similar ways. The findings will be presented during a poster presentation on Thursday, Nov. 5, at The Obesity Society Annual Meeting at ObesityWeek 2015 in Los Angeles, CA. When the body becomes less sensitive to insulin (i.e., "insulin resistant"), it needs to produce more insulin to keep blood sugar stable. This may eventually lead to Type 2 diabetes, a disease where the body's insulin response doesn't work properly and there is too much sugar in the blood. Diabetes is associated with a number of serious complications, including heart disease. Individuals with obesity are more likely to develop insulin resistance and subsequently, diabetes. "Research has shown that sleep deficiency and a high-fat diet both lead to impaired insulin sensitivity, but it was previously unknown which leads to more severe insulin resistance," said Dr. Broussard. "Our study suggests that one night of total sleep deprivation may be as detrimental to insulin sensitivity as six months on a high-fat diet. This research demonstrates the importance of adequate sleep in maintaining blood sugar levels and reducing risk for metabolic diseases like obesity and diabetes."   To conduct the study, the researchers measured insulin sensitivity in eight male dogs before and after diet-induced obesity. Prior to the high-fat feeding, researchers used an IV glucose tolerance test to measure insulin sensitivity in dogs that had one night of sleep deprivation, and compared results to dogs that had a normal night's sleep. The dogs were then fed a high-fat diet for six months, at which point they were tested again. Prior to the high-fat diet, one night of sleep deprivation reduced insulin sensitivity by 33%; this reduction was similar to the reduction caused by a high-fat diet alone (21%). Once the dogs had impaired insulin sensitivity from the high-fat diet, one night of sleep deprivation did not further impair the insulin sensitivity.   "One night of sleep deprivation and six months of a high-fat diet both reduced insulin sensitivity by a similar degree in canines; however, there was no additive effect of sleep loss and high-fat diet," continued Dr. Broussard. "This may suggest a similar mechanism by which both insufficient sleep and a high-fat diet induce insulin resistance. It could also mean that after high-fat feeding, insulin sensitivity cannot be reduced further by sleep loss."   In addition to impaired insulin sensitivity, sleep deprivation can lead to increased food intake and overall increased risk for metabolic diseases.   "It is critical for health practitioners to emphasize the importance of sleep to their patients," said Caroline M. Apovian, MD, FACP, FACN, a Fellow and spokesperson for The Obesity Society. "Many patients understand the importance of a balanced diet, but they might not have a clear idea of how critical sleep is to maintaining equilibrium in the body."   According to Dr. Broussard, future research should examine the pathways that may account for the interactions between sleep and diet and their relationship to insulin sensitivity. It will also be important to determine whether insulin sensitivity is improved after recovery sleep, which is beginning to be addressed in clinical studies.   These types of basic science studies and canine models are critical in helping to understand the causes and complications of obesity and to identify mechanisms that lead to its prevention or cure.   The full abstract is available below.   Author Josiane Broussard, PhD, Cedars-Sinai Medical Center Abstract Sleep deprivation and fat feeding may reduce insulin action by similar mechanistic pathways Background Sleep deficiency leads to impaired insulin sensitivity. Similarly, a long term high fat diet leading to increase adiposity causes insulin resistance. To address the question of whether these two causes of insulin resistance are due similar mechanisms, we examined the impact of sleep deprivation in a canine model before and after the development of diet-induced obesity. Methods At baseline and after 6 months of a high fat diet, 8 male dogs underwent 2 sleep conditions—1 night of habitual sleep and 1 night of sleep deprivation. Each sleep condition was followed by an IV glucose tolerance test to assess insulin action and beta-cell response. Results Prior to the high fat diet, 1 night of sleep deprivation significantly reduced insulin sensitivity. This reduction was similar to that caused by a high fat diet alone. Sleep deprivation after the high fat diet did not further reduce insulin sensitivity. Conclusion Sleep deprivation alone was associated with a 33% decrease in insulin sensitivity with no compensatory insulin response. Fat feeding alone for 6 months similarly reduced insulin sensitivity by 21%, which was not significantly reduced further by 1 night of sleep deprivation. This study suggests that because sleep loss and high fat diet are not additive in their impairment of insulin sensitivity, they may act by similar mechanisms. Future studies are necessary to determine the pathways that may account for the interactions between sleep and diet and their relationship to insulin resistance. Citation Broussard J. Cedars-Sinai Medical Center. Poster abstract presentation at: The Obesity Society Annual Meeting at ObesityWeekSM 2015; November 2-6, 2015; Los Angeles, CA. www.obesityweek.com . This press release can be published in full or in part with attribution to The Obesity Society. About The Obesity Society

The Obesity Society (TOS) is the leading professional society dedicated to better understanding, preventing and treating obesity. Through research, education and advocacy, TOS is committed to improving the lives of those affected by the disease. For more information visit: www.Obesity.org . Connect with us on social media: Facebook , Twitter and LinkedIn . Find TOS disclosures here . About ObesityWeek 2015

ObesityWeek is the premier, international event focused on the basic science, clinical application, prevention and treatment of obesity. TOS and the American Society for Metabolic and Bariatric Surgery (ASMBS) host the world's pre-eminent conference on obesity, ObesityWeek 2015, Nov. 2-6, at the Los Angeles Convention Center in Los Angeles, California. For the third year, both organizations hold their respective annual scientific meetings under one roof to unveil exciting new research, discuss emerging treatment and prevention options, and network and present. Connect and share with ObesityWeek on Twitter and Facebook , or by using #OW2015.

Chelsea Clark The Obesity Society

Scroll down for more posts ▼

Top 10 Most Recent News Articles

iScooter's Bold Black Friday Launch Targets All Ages

Updated Category News Views 5

Revving Up for Black Friday Scootering Alright folks, we're diving headfirst into iScooter's ambitious 2026 Black Friday campaign, and boy, it’s packed to the rafters. Running from October 20 to November 30, they're littering the market with discounts, sparking the interest of adults and kids alike with their electric two-wheelers. Not just another Holiday marketing...

Continue Reading
Barco, VUE Partner to Elevate German Cinemas

Updated Category News Views 0

Alright, cinema tech enthusiasts, gather up. Remember when going to the movies was just about the popcorn and hoping the ticket lines were short? Now we're witnessing cinema transform into an all-out tech arena, and that’s where Barco and VUE come into play. It seems these folks have decided the German film scene deserves a makeover. Yep, we're talking about pimping out...

Continue Reading
CGTN Introduces AI-Driven News Pal for Global Views

Updated Category News Views 2

News Pal: A New Spin on Global Reporting Folks in the newsroom are buzzing about CGTN’s fresh-faced brainchild, News Pal. This isn’t your run-of-the-mill news brief; we’re talking about a web-based AI contraption that’s flipping the script on how we digest the heap of headlines thrown at us every day. Launched mid-October, News Pal’s in the business of...

Continue Reading
Endeavour and Trevi Turn Data Centers Into Water Sources

Updated Category News Views 7

Turning Data Centers Into Wells If you'd told me data centers could double as water sources, I'd have laughed you off. But this week brings us a game-changing partnership between Endeavour and Trevi Systems. They're using the waste heat from data centers to create clean water, tackling water scarcity in the process. Imagine this: for every megawatt of computing power, up...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 4

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
AHN Launches Cancer Screenings at Work; Dollar Bank First

Updated Category News Views 3

Pioneering Workplace Cancer Screening Initiative In a move that could redefine preventive healthcare, Allegheny Health Network (AHN) Cancer Center is taking cancer screenings right to the workplace. This initiative isn't just a new gimmick—it's a smart pivot in delivering healthcare where it's most convenient for employees. Here's looking at you, Dollar Bank, for being...

Continue Reading
Tierra Encantada Expands Into North Carolina Market

Updated Category News Views 2

Tierra Encantada is making its way down to the Tar Heel State, bringing its Spanish Immersion Early Education® program to the thriving community of Raleigh. Talk about catching the right wave at the right time. With a burgeoning demand for quality early education in fast-growing markets, Tierra Encantada's expansion into North Carolina seems like a no-brainer. Raleigh:...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 2

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
LianLian and PayPal: Transforming Creator Payouts Globally

Updated Category News Views 1

Social Commerce Meets Seamless Payments Ah, the sweet smell of global payments getting a makeover—it’s about time! LianLian Global's new dance with PayPal (NASDAQ:PYPL) is turning heads, pushing boundaries, and setting an entirely new stage for the gig economy. With LianLian’s clients now able to zap payments directly into PayPal and Venmo accounts, creators and...

Continue Reading
Chery's TIGGO7 Crash Test Sparks Family Safety Confidence

Updated Category News Views 0

Safety Is More Than a Buzzword for CHERY In the world of automobile mayhem, CHERY's "Guardian. For Family" event threw down the gauntlet, showing they ain't just playing with fire—they're harnessing it for family safety. Now, over in Longshan Crash Laboratory in Wuhu, we got to see the TIGGO7 take a 50 km/h head-on collision with a truck. Yeah, it's as dramatic as it...

Continue Reading

Top 5 Most Recently Viewed Articles

Zenas BioPharma Celebrates Major Milestones in Q3 2025

Updated Category News Views 245

Zenas BioPharma Celebrates Major Milestones in Q3 2025 - Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end. - Reported highly positive 12-week primary endpoint results from Phase 2 MoonStone trial of obexelimab in Relapsing MS (RMS). - Secured development and commercialization rights for three...

Continue Reading
Transforming Business Culture: A Call for Excellence

Updated Category News Views 98

Transforming Business Culture: A Call for Excellence In today's dynamic corporate landscape, where competition is fierce and expectations are high, settling for mediocrity is not an option. Bestselling author and leadership expert John Rossman has articulated this challenge in his new work, “The Pig, The Lipstick and the Three Pillars of Champions: Reclaiming Your...

Continue Reading
Kroger Family Commits $1M to Aid Families Affected by Wildfires

Updated Category News Views 446

Kroger Takes Action to Support Families Affected by Wildfires The Kroger Family of Companies has announced a generous commitment of $1 million to aid families in need due to the recent wildfires affecting various regions. This significant pledge is not just financial support; it encompasses the very essence of Kroger's commitment to its communities. Purpose Behind the...

Continue Reading
New Trading Option for NMP Acquisition Corp's Shares and Rights

Updated Category News Views 123

NMP Acquisition Corp. Announces New Trading Opportunities for Shareholders NMP Acquisition Corp. (NASDAQ: NMPAU) has exciting news for its investors. Starting September 3, 2025, those who participated in the company’s initial public offering will have the option to trade their Class A ordinary shares and rights separately. This development offers shareholders increased...

Continue Reading
Outcomes4Me Revolutionizes Cancer Care with Recognition

Updated Category News Views 186

Outcomes4Me Recognized Among TIME's Innovations In a remarkable achievement, Outcomes4Me has been named to TIME's Best Inventions of 2025 list, solidifying its place as a pioneering force in cancer care solutions. As a leading, AI-driven patient empowerment platform, Outcomes4Me assists cancer patients from diagnosis through every phase of their journey. With a user base...

Continue Reading